Added to YB: 2024-04-12
Pitch date: 2024-04-09
MEDP [neutral]
Medpace Holdings, Inc.
+25.57%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
Market Cap
$12.8B
Pitch Price
$395.01
Price Target
N/A
Dividend
N/A
EV/EBITDA
20.52
P/E
29.53
EV/Sales
4.92
Sector
Life Sciences Tools and Services
Category
growth
Show full summary:
ClearBridge Small Cap Growth Strategy New Position: Medpace Holdings, Inc.
MEDP: Medpace provides clinical research services to small-midsize biotech. Full-service focus enables above-peer growth, strong profitability & cash flow generation. Well-positioned to capitalize on biotech outsourcing trend.
Read full article (1 min)